{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:36:44Z","timestamp":1791855404568,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T00:00:00Z","timestamp":1410307200000},"content-version":"vor","delay-in-days":344,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"CNPq (Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico)"},{"name":"CAPES (Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gene"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.gene.2013.06.091","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T05:02:10Z","timestamp":1374642130000},"page":"326-331","source":"Crossref","is-referenced-by-count":33,"title":["Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: A study in Brazilian patients"],"prefix":"10.1016","volume":"529","author":[{"given":"Fernanda Aparecida","family":"Domenici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9 Franco","family":"Brochado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana de Lourdes Candolo","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Zucoloto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma Freire de Carvalho","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helio","family":"Vannucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.gene.2013.06.091_bb0040","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1111\/j.1572-0241.2001.04129.x","article-title":"Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study","volume":"96","author":"Abdelmalek","year":"2001","journal-title":"Am. J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.gene.2013.06.091_bb0155","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1161\/01.STR.0000138784.68159.a5","article-title":"Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis","volume":"35","author":"Al-Shali","year":"2004","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.gene.2013.06.091_bb0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/79216","article-title":"The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes","volume":"26","author":"Altshuler","year":"2000","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.gene.2013.06.091_bb0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"issue":"2 Suppl.","key":"10.1016\/j.gene.2013.06.091_bb0115","doi-asserted-by":"crossref","first-page":"488S","DOI":"10.1093\/ajcn\/55.2.488s","article-title":"Pathophysiology of obesity","volume":"55","author":"Bray","year":"1992","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.gene.2013.06.091_bb0055","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cld.2009.07.008","article-title":"Histopathology of non-alcoholic fatty liver disease","volume":"13","author":"Brunt","year":"2009","journal-title":"Clin. Liver Dis."},{"issue":"4","key":"10.1016\/j.gene.2013.06.091_bb0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrgastro.2010.21","article-title":"Pathology of nonalcoholic fatty liver disease","volume":"7","author":"Brunt","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.gene.2013.06.091_bb0105","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.gene.2013.06.091_bb0265","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1440-1746.2008.05523.x","article-title":"A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio","volume":"23","author":"Chen","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.gene.2013.06.091_bb0200","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.yexmp.2009.10.001","article-title":"Association of PPARalpha gene polymorphisms and lipid serum levels in a Brazilian elderly population","volume":"88","author":"Chen","year":"2010","journal-title":"Exp. Mol. Pathol."},{"issue":"3","key":"10.1016\/j.gene.2013.06.091_bb0260","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MOG.0b013e3283294a18","article-title":"Recent advances in nonalcoholic fatty liver disease","volume":"25","author":"Cheung","year":"2009","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.gene.2013.06.091_bb0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1665-2681(19)31584-4","article-title":"Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile","volume":"10","author":"Cotrim","year":"2011","journal-title":"Ann. Hepatol."},{"issue":"5","key":"10.1016\/j.gene.2013.06.091_bb0020","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.23567","article-title":"Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease","volume":"51","author":"Das","year":"2010","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.gene.2013.06.091_bb0015","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.jhep.2008.01.009","article-title":"Non-alcoholic fatty liver disease: the mist gradually clears","volume":"48","author":"de Alwis","year":"2008","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.gene.2013.06.091_bb0125","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/sj.ijo.0800741","article-title":"Body mass index and percent body fat: a meta analysis among different ethnic groups","volume":"22","author":"Deurenberg","year":"1998","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.gene.2013.06.091_bb0165","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-230X-10-102","article-title":"Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study","volume":"10","author":"Dongiovanni","year":"2010","journal-title":"BMC Gastroenterol."},{"issue":"30","key":"10.1016\/j.gene.2013.06.091_bb0085","doi-asserted-by":"crossref","first-page":"18779","DOI":"10.1074\/jbc.272.30.18779","article-title":"The organization, promoter analysis, and expression of the human PPARgamma gene","volume":"272","author":"Fajas","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.gene.2013.06.091_bb0030","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2005.02.042","article-title":"Prevalence of and risk factors for fatty liver in a general population of Shanghai, China","volume":"43","author":"Fan","year":"2005","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.gene.2013.06.091_bb0075","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s001250051357","article-title":"Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects","volume":"43","author":"Flavell","year":"2000","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.gene.2013.06.091_bb0110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.gene.2013.06.091_bb0275","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s10620-011-1994-2","article-title":"Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD","volume":"57","author":"Gawrieh","year":"2012","journal-title":"Dig. Dis. Sci."},{"issue":"11","key":"10.1016\/j.gene.2013.06.091_bb0120","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.gene.2013.06.091_bb0220","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/aje\/kwp450","article-title":"The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis","volume":"171","author":"Gouda","year":"2010","journal-title":"Am. J. Epidemiol."},{"issue":"8","key":"10.1016\/j.gene.2013.06.091_bb0140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/00042737-200508000-00010","article-title":"Non-alcoholic fatty liver disease and insulin resistance: importance of risk factors and histological spectrum","volume":"17","author":"Guidorizzi de Siqueira","year":"2005","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.gene.2013.06.091_bb0185","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s12072-010-9225-z","article-title":"Peroxisome proliferators-activated receptor gamma2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients","volume":"5","author":"Gupta","year":"2010","journal-title":"Hepatol. Int."},{"issue":"19","key":"10.1016\/j.gene.2013.06.091_bb0280","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","author":"JAMA","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.gene.2013.06.091_bb0245","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0021-9150(02)00002-3","article-title":"Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial","volume":"163","author":"Jamshidi","year":"2002","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.gene.2013.06.091_bb0235","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ng1071","article-title":"Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease","volume":"33","author":"Lohmueller","year":"2003","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.gene.2013.06.091_bb0225","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/oby.2007.617","article-title":"Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk","volume":"15","author":"Ludovico","year":"2007","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"10.1016\/j.gene.2013.06.091_bb0005","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.gene.2013.06.091_bb0180","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1590\/S0100-879X2006005000114","article-title":"Effects of a PPARG gene variant on obesity characteristics in Brazil","volume":"40","author":"Mattevi","year":"2007","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"7","key":"10.1016\/j.gene.2013.06.091_bb0135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.gene.2013.06.091_bb0205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymgme.2010.11.156","article-title":"PPARalpha polymorphisms as risk factors for dyslipidemia in a Brazilian population","volume":"102","author":"Mazzotti","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.gene.2013.06.091_bb0145","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.gene.2013.06.091_bb0095","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2337\/diabetes.50.4.891","article-title":"The Pro12\u2192Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes","volume":"50","author":"Mori","year":"2001","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.gene.2013.06.091_bb0250","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00008571-200307000-00007","article-title":"Evidence for an association between the Leu162Val polymorphism of the PPARalpha gene and decreased fasting serum triglyceride levels in glucose tolerant subjects","volume":"13","author":"Nielsen","year":"2003","journal-title":"Pharmacogenetics"},{"issue":"2","key":"10.1016\/j.gene.2013.06.091_bb0230","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/B:REMD.0000021437.46773.26","article-title":"Candidate genes for type 2 diabetes","volume":"5","author":"Parikh","year":"2004","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"1","key":"10.1016\/j.gene.2013.06.091_bb0060","first-page":"9","article-title":"Non alcoholic fatty liver disease and metabolic syndrome","volume":"13","author":"Paschos","year":"2009","journal-title":"Hippokratia"},{"issue":"9","key":"10.1016\/j.gene.2013.06.091_bb0045","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.dld.2009.01.004","article-title":"Non-alcoholic fatty liver disease pathogenesis: the present and the future","volume":"41","author":"Petta","year":"2009","journal-title":"Dig. Liver Dis."},{"issue":"5","key":"10.1016\/j.gene.2013.06.091_bb0175","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2337\/dc05-1473","article-title":"Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: evidence for heterogeneity","volume":"29","author":"Radha","year":"2006","journal-title":"Diabetes Care"},{"issue":"46","key":"10.1016\/j.gene.2013.06.091_bb0255","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.3748\/wjg.v16.i46.5830","article-title":"Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma2 in patients with fatty liver diseases","volume":"16","author":"Rey","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.gene.2013.06.091_bb0240","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s10038-004-0177-9","article-title":"Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome","volume":"49","author":"Robitaille","year":"2004","journal-title":"J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.gene.2013.06.091_bb0270","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/hep.23759","article-title":"The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease","volume":"52","author":"Rotman","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.gene.2013.06.091_bb0160","first-page":"914","article-title":"Rapid silver staining and recovery of PCR products separated on polyacrylamide gels","volume":"17","author":"Sanguinetti","year":"1994","journal-title":"Biotechniques"},{"issue":"4","key":"10.1016\/j.gene.2013.06.091_bb0080","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00008571-200006000-00006","article-title":"The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants","volume":"10","author":"Sapone","year":"2000","journal-title":"Pharmacogenetics"},{"issue":"3","key":"10.1016\/j.gene.2013.06.091_bb0215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0028-1082069","article-title":"The L162V polymorphism of the peroxisome proliferator activated receptor alpha gene (PPARA) is not associated with type 2 diabetes, BMI or body fat composition","volume":"117","author":"Silbernagel","year":"2009","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"3","key":"10.1016\/j.gene.2013.06.091_bb0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/10408363.2011.596521","article-title":"Non-alcoholic fatty liver disease","volume":"48","author":"Smith","year":"2011","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"5","key":"10.1016\/j.gene.2013.06.091_bb0190","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1463-1326.2004.00453.x","article-title":"Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus","volume":"7","author":"Tavares","year":"2005","journal-title":"Diabetes Obes. Metab."},{"issue":"7","key":"10.1016\/j.gene.2013.06.091_bb0210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2310\/6650.2005.53706","article-title":"Peroxisome proliferator-activated receptor alpha L162V polymorphism in nonalcoholic steatohepatitis and genotype 1 hepatitis C virus-related liver steatosis","volume":"53","author":"Verdi","year":"2005","journal-title":"J. Investig. Med."},{"issue":"2","key":"10.1016\/j.gene.2013.06.091_bb0195","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2337\/diacare.27.2.621","article-title":"Influence of the polymorphisms Tpr64Arg in the beta 3-adrenergic receptor gene and Pro12Ala in the PPAR gamma 2 gene on metabolic syndrome-related phenotypes in an indigenous population of the Brazilian Amazon","volume":"27","author":"Vieira-Filho","year":"2004","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.gene.2013.06.091_bb0150","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0022-2275(20)32037-X","article-title":"Molecular scanning of the human PPARa gene: association of the L162v mutation with hyperapobetalipoproteinemia","volume":"41","author":"Vohl","year":"2000","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.gene.2013.06.091_bb0050","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.22603","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management","volume":"49","author":"Vuppalanchi","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gene.2013.06.091_bb0170","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/bbrc.1997.7798","article-title":"Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation","volume":"241","author":"Yen","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.gene.2013.06.091_bb0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MOL.0b013e3282f64542","article-title":"Single gene contributions: genetic variants of peroxisome proliferator-activated receptor (isoforms alpha, beta\/delta and gamma) and mechanisms of dyslipidemias","volume":"19","author":"Yong","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"issue":"7","key":"10.1016\/j.gene.2013.06.091_bb0025","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1478-3231.2006.01311.x","article-title":"Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures","volume":"26","author":"Zelber-Sagi","year":"2006","journal-title":"Liver Int."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111913008883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111913008883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T18:54:21Z","timestamp":1646160861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111913008883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0378111913008883"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2013.06.091","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}